The potential cost-savings of tumour necrosis factor inhibitors for hidradenitis suppurativa
- PMID: 31025755
- DOI: 10.1111/bjd.17729
The potential cost-savings of tumour necrosis factor inhibitors for hidradenitis suppurativa
Comment on
-
Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort.Br J Dermatol. 2019 May;180(5):1161-1168. doi: 10.1111/bjd.17151. Epub 2018 Nov 4. Br J Dermatol. 2019. PMID: 30192377
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical